Comparison of the difference between Xilone and Xilone Forte for allergy treatment

Both Xilone Syrup and Xilone Forte Syrup are used to reduce inflammation and treat a variety of medical conditions that respond to corticosteroids. The primary difference between them lies in the concentration of the active ingredient, prednisolone, resulting in differences in the recommended dosage, age groups, and conditions for which each is used.

Xilone Syrup Ingredients

Xilone Syrup contains the active ingredient prednisolone at a concentration of 5 mg per 5 ml. Prednisolone is a synthetic corticosteroid with powerful anti-inflammatory and immunosuppressive properties. It works by inhibiting the release of chemicals that cause inflammation in the body.

Xilone Forte Syrup Ingredients

Xilone Forte Syrup also contains the active ingredient prednisolone, but at a higher concentration of 15 mg per 5 ml. This higher concentration often allows for lower doses or fewer administrations to achieve the same therapeutic effect and is generally suitable for adults and older children who require higher doses.

Information about Xilone Syrup

Drug Class: Systemic Corticosteroids

Drug Classification: Glucocorticoids

Pharmaceutical Form: Syrup

Pharmaceutical Family: Hormonal Drugs

Active Ingredient: Prednisolone (5 mg/5 ml)

Information about Xilone Forte Syrup

Drug Class: Systemic Corticosteroids

Drug Classification: Glucocorticoids

Pharmaceutical Form: Syrup

Pharmaceutical Family: Hormonal Drugs

Active Ingredient: Prednisolone (15 mg/5 ml)

Author Name: Pharmacist Rawan Mossad Elsaed

Scientific Degree: Pharmacist

Country: Egypt

Dr. Rawan Mosaad El-Saeed is a clinical pharmacist and medical content reviewer holding a Bachelor of Pharmacy degree from Horus University in Egypt. She has hands-on community pharmacy experience in providing medication therapy counseling, monitoring drug-drug interactions, and ensuring patient adherence to safe usage protocols. She specializes in authoring and fact-checking pharmaceutical guides and simplifying clinical pharmacology based on the latest evidence-based guidelines and internationally accredited references, dedicated to delivering accurate, reliable, and safe healthcare information for readers.

Published Date: 17 April 2025